Frontlight ResearchEarly access
Pulmonary arterial hypertension trials in United States
110 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peoplePulmonary Hypertension (PH) Biorepository for Translational Research
- Where
- Baltimore, Bethesda, Falls Church
- Age
- 18 years to 100 years
- People
- 1,000
- Run by
- National Institutes of Health Clinical Center (CC)
See details and how to joinNCT07647549 - Phase 2Not yet taking people in United StatesLAM-001 for the Treatment of Sarcoidosis Associated Pulmonary Hypertension (SAPH)
- Where
- Philadelphia
- Age
- 18 years to 80 years
- People
- 60
- Run by
- IRulya Therapeutics Inc.
See details and how to joinNCT07886554 - Phase 3Enrolling by invitationLong-Term Open-Label Extension Study of Oral Levosimendan
- Where
- Boston, Charleston, Chicago, Durham, Madison, Minneapolis, New York, Omaha, Rochester, St Louis
- Age
- 18 years and over
- People
- 800
- Run by
- Tenax Therapeutics, Inc.
See details and how to joinNCT07436689 - Phase 2Taking peopleLAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Where
- Boston, New Haven, Philadelphia, Tucson
- Age
- 18 years to 85 years
- People
- 85
- Run by
- IRulya Therapeutics Inc.
See details and how to joinNCT05798923 - No phaseTaking peopleUnderstanding the Effects of Pulmonary Arterial Hypertension on Lean Muscle Mass
- Where
- Philadelphia, Providence
- Age
- 18 years and over
- People
- 150
- Run by
- University of Pennsylvania
See details and how to joinNCT07132788 - Phase 3Taking peopleA Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
- Where
- Aurora, Bend, Charleston, Chicago, Denver, Indianapolis, Los Angeles, New York, Phoenix, Rochester, San Francisco, Scottsdale, Tampa
- Age
- 18 years to 80 years
- People
- 344 worldwide
- Run by
- Liquidia Technologies, Inc.
See details and how to joinNCT07285655 - Phase 3Taking peopleOpen-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
- Where
- Albuquerque, Ann Arbor, Atlanta, Chapel Hill, Charleston, Chicago, Cincinnati, Dallas, Falls Church, Fresno, Gainesville, Houston, Jacksonville, Kansas City, Los Angeles, Louisville, Murray, New York, Oklahoma City, Omaha, Philadelphia, Pittsburgh, Richmond, Rochester, Sacramento, Salt Lake City, San Antonio, Stanford, St Louis
- Age
- 18 years to 75 years
- People
- 330 worldwide
- Run by
- Gossamer Bio USA, Inc.
See details and how to joinNCT06274801 · EU 2023-506334-75-00 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
- Where
- Anderson, Kansas City, Los Angeles, New Hyde Park, New York, Omaha, Philadelphia, Rochester, Santa Barbara, Torrance
- Age
- 18 years to 75 years
- People
- 344 worldwide
- Run by
- Insmed Incorporated
See details and how to joinNCT07481981 · EU 2026-525265-48-00 - Phase 3Enrolling by invitationA Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
- Where
- Albuquerque, Atlanta, Aurora, Austell, Austin, Baltimore, Boston, Burlington, Chicago, Cincinnati, Columbus, Dallas, Denver, Durham, Elk Grove Village, Gainesville, Grand Rapids, Greenville, Houston, Indianapolis, Iowa City, Knoxville, La Jolla, Los Angeles, Milwaukee, New York, Oklahoma City, Orange, Orlando, Philadelphia, Phoenix, Pittsburgh, Portland, Roanoke, Rochester, Sacramento, Santa Barbara, Stanford, St Louis, Tucson, Weston
- Age
- 18 years and over
- People
- 1,000 worldwide
- Run by
- United Therapeutics
See details and how to joinNCT03683186 · EU 2023-509305-68-00 - No phaseTaking peoplePulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants
- Where
- Birmingham, New Haven
- Age
- 1 month to 5 months
- People
- 39
- Run by
- University of Alabama at Birmingham
See details and how to joinNCT06373289 - Phase 4Taking peopleA Study of Inhaled Treprostinil (LIQ861) in Adults With Pulmonary Arterial Hypertension Transitioning From Oral Selexipag
- Where
- Columbus
- Age
- 18 years to 80 years
- People
- 20
- Run by
- Liquidia Technologies, Inc.
See details and how to joinNCT07759804 - No phaseTaking peopleHormonal, Metabolic, and Signaling Interactions in PAH
- Where
- Nashville
- Age
- Up to 90 years
- People
- 1,899
- Run by
- Vanderbilt University Medical Center
See details and how to joinNCT01884051 - Phase 1Taking people: Vascular Function in Health and Disease
- Where
- Salt Lake City
- Age
- 18 years and over
- People
- 420
- Run by
- D. Walter Wray
See details and how to joinNCT02966665 - Early phase 1Taking peopleEarly Intervention With Inhaled Treprostinil Among Patients With Exercise-Induced Pulmonary Hypertension (EPIH)
- Where
- Paramus
- Age
- 18 years and over
- People
- 32
- Run by
- Valley Health System
See details and how to joinNCT07837830 - No phaseEnrolling by invitationPulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension Group 2 (PreVail-PH2 Study)
- Where
- Boston, Charleston, Chicago, Durham, Houston, Madison, Milwaukee
- Age
- 22 years to 85 years
- People
- 50
- Run by
- Gradient Denervation Technologies
See details and how to joinNCT06052072 - No phaseEnrolling by invitationGlobal Utilization And Registry Database for Improved preservAtion of doNor LUNGs
- Where
- Baltimore, Boston, Charlottesville, Dallas, Durham, Houston, Jacksonville, Philadelphia, Phoenix, Pittsburgh, San Francisco, Stanford, The Bronx
- People
- 3,500 worldwide
- Run by
- Paragonix Technologies
See details and how to joinNCT04930289 - Phase 1/2Not yet taking people in United StatesTEPH: Telaglenastat Efficacy in Pulmonary Hypertension
- Where
- Pittsburgh
- Age
- 18 years to 75 years
- People
- 28
- Run by
- Chan, Stephen, MD, PhD
See details and how to joinNCT07223528 - Phase 3Taking peopleA Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
- Where
- Bend, Kissimmee, Louisville
- Age
- 18 years to 85 years
- People
- 376
- Run by
- Pulmovant, Inc.
See details and how to joinNCT07816185 - No phaseEnrolling by invitationMultimodal Physiologic State Intelligence Study
- Where
- New York
- Age
- 18 years and over
- People
- 25,000
- Run by
- Truway Health, Inc.
See details and how to joinNCT07814118 - No phaseTaking peopleRight Ventricular Pacing in Pulmonary Arterial Hypertension
- Where
- San Francisco
- Age
- 18 years to 75 years
- People
- 16
- Run by
- University of California, San Francisco
See details and how to joinNCT04194632 - Phase 2Taking peopleA Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
- Where
- Albuquerque, Ann Arbor, Boston, Charleston, Chicago, Detroit, Greensboro, Houston, Kansas City, Kissimmee, Providence, Santa Barbara, Torrance
- Age
- 18 years to 85 years
- People
- 20
- Run by
- Pulmovant, Inc.
See details and how to joinNCT07333183 - Phase 3Taking peopleAn Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
- Where
- Aurora, Beverly Hills, Boston, Cincinnati, Dallas, Durham, Kansas City, Louisville, Nashville, New York, Santa Barbara, Scottsdale, St Louis, Torrance, Valhalla
- Age
- 18 years to 75 years
- People
- 486 worldwide
- Run by
- Inhibikase Therapeutics
See details and how to joinNCT07365332 · EU 2024-520218-23-00 - No phaseTaking peopleDeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Where
- Albuquerque, Anderson, Atlanta, Aurora, Baltimore, Bend, Bethlehem, Birmingham, Chapel Hill, Charleston, Chicago, Cincinnati, Cleveland, Columbus, Dallas, Denver, Durham, Falls Church, Gainesville, Greensboro, Greenville, Houston, Huntington, Indianapolis, Kansas City, Knoxville, Lebanon, Los Angeles, Louisville, Madison, Maywood, Milwaukee, Morristown, Murray, Naples, Neptune City, New Hyde Park, New Orleans, New York, Norfolk, Oak Lawn, Oklahoma City, Orlando, Philadelphia, Phoenix, Portland, Raleigh, Richmond, Rochester, Sacramento, Salt Lake City, Sarasota, St Louis, Tampa, Troy, Tulsa, Washington D.C., Weston
- Age
- 18 years and over
- People
- 900 worldwide
- Run by
- United Therapeutics
See details and how to joinNCT06388421 - No phaseTaking peopleDevelopment of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope
- Where
- Providence
- Age
- 18 years and over
- People
- 2,420
- Run by
- Eko Devices, Inc.
See details and how to joinNCT05873387 - No phaseTaking peopleDetecting Pulmonary Hypertension With the Eko CORE 500 Digital Stethoscope
- Where
- Durham, Los Angeles
- Age
- 18 years and over
- People
- 1,513
- Run by
- Eko Devices, Inc.
See details and how to joinNCT07136623